We are live on ! Find out more
CALA

Calithera Biosciences, Inc
CALA

Delisted

CALA was delisted on the 1st of February, 2023.

Back to rankings

28 hedge funds and large institutions have $4.44M invested in Calithera Biosciences, Inc in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% less funds holding

Funds holding: 54 → 28 (-26)

50% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 14

75% less capital invested

Capital invested by funds: $17.9M → $4.44M (-$13.5M)

81% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 32

Holders
28
Holders Change
-26
Holders Change %
-48.15%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
14
Closed
32
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$261K
2
TRCT
Tower Research Capital (TRC)
New York
+$67.2K
3
Citadel Advisors
Citadel Advisors
Florida
+$54.2K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$47.2K
5
VF
Virtu Financial
New York
+$46.5K

Top Sellers

Rank Fund Capital Flow
1
Primecap Management
Primecap Management
California
-$539K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$502K
3
AAA
Affinity Asset Advisors
New York
-$404K
4
EAM
Empery Asset Management
New York
-$313K
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$304K
Name Holding Trade Value Shares
Change 		Change in
Stake
LC
26
Lindbrook Capital
California
$1K +$2.32K +500 New
Two Sigma Advisers
27
Two Sigma Advisers
New York
– -$502K -62,125 Closed
AAA
28
Affinity Asset Advisors
New York
– -$404K -50,000 Closed
EAM
29
Empery Asset Management
New York
– -$313K -38,796 Closed
Assenagon Asset Management
30
Assenagon Asset Management
Luxembourg
– -$304K -37,684 Closed
Millennium Management
31
Millennium Management
New York
– -$260K -32,160 Closed
SCM
32
Silverarc Capital Management
Massachusetts
– -$74 -11,090 Closed
ACM
33
Altium Capital Management
New York
– -$82K -10,114 Closed
Truist Financial
34
Truist Financial
North Carolina
– -$81K -10,000 Closed
BCM
35
Bridgeway Capital Management
Texas
– -$74K -9,175 Closed
Northern Trust
36
Northern Trust
Illinois
– -$61K -7,534 Closed
FSA
37
Franklin Street Advisors
North Carolina
– -$54K -6,685 Closed
Franklin Resources
38
Franklin Resources
California
– -$54K -6,660 Closed
Goldman Sachs
39
Goldman Sachs
New York
– -$50K -6,187 Closed
B
40
Bailard
California
– -$49K -6,114 Closed
GCP
41
GSA Capital Partners
United Kingdom
– -$33K -4,128 Closed
AI
42
Atom Investors
Texas
– -$27K -3,391 Closed
Tudor Investment Corp
43
Tudor Investment Corp
Connecticut
– -$27K -3,348 Closed
Bank of New York Mellon
44
Bank of New York Mellon
New York
– -$13K -1,554 Closed
HF
45
HRT Financial
New York
– -$12K -1,522 Closed
KAS
46
Kestra Advisory Services
Texas
– -$8K -1,000 Closed
TCM
47
Traynor Capital Management
Pennsylvania
– -$8K -1,000 Closed
SAM
48
Seelaus Asset Management
New Jersey
– -$7K -820 Closed
Osaic Holdings
49
Osaic Holdings
Arizona
– -$4K -795 Closed
TCA
50
Transcend Capital Advisors
New Jersey
– -$6K -739 Closed
1
2
3

CALA Hedge Fund Activity: Q2 2022 in Review

28 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q2 2022, worth a combined $4.44M — down 75% from $17.9M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of CALA and 6 opened new positions — a net loss of 26 holders — while 14 trimmed existing stakes and 7 added.

The largest buyer was Acadian Asset Management, adding an estimated $261K. The largest seller was Primecap Management, cutting an estimated $539K.

  • 28 institutional investors held Calithera Biosciences, Inc (CALA) as of Q2 2022, down from 54 in Q1 2022.
  • Funds reported $4.44M of Calithera Biosciences, Inc stock for Q2 2022, down 75% quarter-over-quarter.
  • 6 funds opened new Calithera Biosciences, Inc positions in Q2 2022 and 32 closed out, a net change of -26 holders.
  • The largest Calithera Biosciences, Inc buyer in Q2 2022 was Acadian Asset Management, an estimated $261K added.
  • The largest Calithera Biosciences, Inc seller in Q2 2022 was Primecap Management, an estimated $539K sold.

Based on aggregated 13F filings for Q2 2022.